Ignite Creation Date:
2024-05-05 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00757835
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2008-09-19
Brief Title:
24-hr IOP With TravoprostTimolol Compared With LatanoprostTimolol in XFG
Sponsor:
Aristotle University Of Thessaloniki
Organization:
Aristotle University Of Thessaloniki
Study Overview
Official Title:
24-hour IOP Control With the TravoprostTimolol Fixed Combination Compared With the LatanoprostTimolol Fixed Combination When Both Are Dosed in the Evening in Patients With Exfoliative Glaucoma
Status:
COMPLETED
Status Verified Date:
2020-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A crossover randomized single-masked study which compares the short-term 3 months 24-hour IOP control and safety of travoprosttimolol fixed combination given once in the evening versus that of latanoprosttimolol fixed combination given once in the evening in patients with exfoliative glaucoma The primary objective of this trial is to compare the quality of 24-hour IOP control after 3 months of chronic therapy with these two medications
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None